一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Biochemical Reagents>Agonist Inhibitors>Upadacitinib
Upadacitinib
  • Upadacitinib
  • Upadacitinib
  • Upadacitinib
  • Upadacitinib
  • Upadacitinib

Upadacitinib NEW

Price Get Latest Price
Package 1Kg/Bag 25Kg/Bag 100Kg/Bag
Min. Order: 1Kg/Bag
Supply Ability: 20 tons
Update Time: 2026-07-02

Product Details

Product Name: Upadacitinib CAS No.: 1310726-60-3
EC-No.: 213-161-9 Min. Order: 1Kg/Bag
Purity: 0.99 Supply Ability: 20 tons
Release date: 2026/07/02

Product Information 


NameUpadacitinib
Other namesUpadacitinib
ABT-494
ABT-494(Upadacitinib) free base
Upadacitinib (ABT-494)
ABT-494 (Upadacitinib)
Upadacitinib (Rinvoq)
ABT-494
CS-2730  
    
Keywords                                  API
CAS NO.1310726-60-3
Molecular FormulaC17H19F3N6O
Molecular Weight380.37g/mol

What is Upadacitinib?    

Upadacitinib (ABT-494) is a Janus kinase 1 (JAK1) inhibitor currently being developed by AbbVie for the treatment of rheumatoid arthritis (RA), Crohn’s disease, ulcerative colitis, atopic dermatitis, and psoriatic arthritis.
It is also being investigated as a potential treatment for people with active ankylosing spondylitis (AS).    Upadacitinib
AS is an inflammatory, progressive autoimmune disease that affects the joints of the spine. As the disease progresses, calcium deposits form where ligaments attach to the bones that form the spine, leading to reduced flexibility of the back.

use    Upadacitinib is a potent and selective Janus kinase (JAK) 1 inhibitor with an IC50 of 43 nM.


Article illustration


Application 

Upadacitinib  function 
Upadacitinib is a JAK1 selective inhibitor being investigated to treat rheumatoid arthritis, Crohn's disease, ulcerative colitis, atopic dermatitis, psoriatic arthritis, axial SpA and Giant Cell Arteritis and Takayasu Arteritis. 
Upadacitinib is a potent and selective Janus kinase (JAK) 1 inhibitor with an IC50 of 43 nM.
Upadacitinib is a JAK1 selective inhibitor being investigated to treat rheumatoid arthritis, Crohn's disease, ulcerative colitis, atopic dermatitis, psoriatic arthritis, axial SpA and Giant Cell Arteritis and Takayasu Arteritis.


Company Information 

Article illustration


Company Profile Introduction

Sinoway Industrial co., ltd. was established in 1987 in Xiamen, China, and now has been a leading group specialized in research, development, custom manufacturing and trading of pharmaceutical intermediates, APIs, health and food supplements, cosmetic raw materials, herbal extracts, polypeptides and prostaglandin derivatives, etc.. We have passed ISO9001:2015. With qualified products, competitive price and excellent service, we have received great reputation of our customers from all over the world, including Southeast Asia, Europe, North America, South America, Middle East and other countries. We have over 20 years good partners in Japan、Korea and Switzerland. Sinoway has a professional R&D team. We have built close cooperative relationships with many research institutes and universities in China. Moreover, Sinoway combines market analysis with technology, providing new business trends to our clients. In addition, we have very close cooperation relationships with many Chinese pharmaceutical factories. These pharmaceutical manufacturers have GMP regulated workshops, advanced production and testing equipments, first-class QC labs and a production team with rich experience. We can supply various Active Pharmaceutical Ingredients and finished products which meet EP/USP/BP standards. Chinese GMP, EU-GMP, COS/CEP certificates with DMF documents are available, and many products have been approved by FDA. We believe that quality and innovation are vital for an enterprise. Adhering to the business philosophy of integrity and win-win cooperation, Sinoway is looking forward to have a bright future with you together.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$1.00
VIP8Y
.GZ HONESTCHEM CO.,LTD
2026-07-02
VIP3Y
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
2026-07-02
VIP6Y
WUHAN FORTUNA CHEMICAL CO., LTD
2026-07-02
VIP2Y
Shaanxi Dideu New Materials Co. Ltd
2026-06-30
$1.00
VIP2Y
S&Y Biochem Co.,Ltd
2026-06-29
VIP3Y
Hangzhou Hyper Chemicals Limited
2026-05-29
$300.00
VIP8Y
Anhui Dexinjia Biopharm Co., Ltd
2026-05-18
VIP4Y
shandong perfect biotechnology co.ltd
2026-03-27
VIP4Y
Hangzhou ICH Biofarm Co., Ltd
2026-01-04
Wuhan Biocar Pharmacy CO.,Ltd.
2025-12-25
  • Since: 1996-07-16
  • Address: 16F,HUICHENG COMM,839 XIAHE ROAD,XIAMEN CHINA
INQUIRY
南岸区| 呼和浩特市| 潜山县| 广昌县| 武川县| 通道| 临高县| 犍为县| 东宁县| 广宗县| 郯城县| 双辽市| 奉新县| 珲春市| 汝城县| 苏州市| 成都市| 离岛区| 南涧| 景东| 温宿县| 闸北区| 抚顺县| 岳普湖县| 宜城市| 湾仔区| 兴文县| 北海市| 高台县| 密云县| 简阳市| 五大连池市| 绥滨县| 东乌珠穆沁旗| 湖北省| 牡丹江市| 昌江| 巢湖市| 临沧市| 长葛市| 绥化市|